MedMira Inc. (TSXV:MIR)
0.0600
-0.0050 (-7.69%)
Oct 9, 2026, 9:30 AM EST
MedMira Market Cap
MedMira has a market cap or net worth of CAD 42.1 million as of October 9, 2026. It is the 34,332nd most valuable company in the world and the 1,034th biggest in Canada. Its market cap has decreased by 33.33% in one year.
Market Cap
42.10M
Enterprise Value
59.53M
Revenue
370.57K
Global Rank
Country Rank
#1,034 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 81.66M to 42.10M, a decrease of -48.44%. That is a compound annual growth rate of -2.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 42.10M | -7.69% |
| Dec 31, 2025 | 45.61M | -31.58% |
| Dec 31, 2024 | 66.66M | -13.11% |
| Dec 29, 2023 | 76.72M | 37.50% |
| Dec 30, 2022 | 55.80M | -60.00% |
| Dec 31, 2021 | 139.49M | -13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 56.87M |
| BriaCell Therapeutics | 49.50M |
| Sernova Biotherapeutics | 45.32M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 43.15M |
| Medicenna Therapeutics | 41.54M |
| Sona Nanotech | 40.52M |
| Thiogenesis Therapeutics | 34.29M |